Aspect Biosystems is a biotechnology company that specializes in the development of 3D tissue models using microfluidics. Their technology platform is designed to enable the creation of living human tissues for drug discovery, therapeutic development, and disease modeling. The company's mission is to revolutionize how the pharmaceutical industry develops drugs by providing more predictive and high-throughput in vitro models.

Aspect Biosystems

Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases. 

Novo Nordisk

Western Innovation (WINN) Initiative

Pacific Economic Development Canada

Innovate BC

Stem Cell Network (SCN)

Genome British Columbia

Rhino Ventures

Pallasite Ventures

Pangaea Ventures

Radical Ventures

Tom Williams

Page One Ventures

2023 was a big year at Aspect! Watch our Year in Review video to see key highlights from the incredible year gone by. 

Looking forward to an exciting 2024 as we continue our mission to develop bioprinted tissue therapeutics to transform the treatment of serious diseases.

#HIRING | Vice President, Process Development & Manufacturing

We are seeking an experienced cell therapy leader with deep expertise in biopharma process development and cGMP manufacturing to join our growing team.

Learn more + apply: https://buff.ly/49tirEU 
#CellTherapy #Biotech #Biomanufacturing

Happy International Day of Women & Girls in Science! 👩‍🔬🔬 

Today, we recognize and celebrate the invaluable contributions of women in STEM globally and right here at Aspect. 

#WomenInScience #WomenInSTEM #February11

Curious what it's like to be a co-op student at Aspect? Watch the video below to hear from past co-ops about their experience with us! 🔬 💻 🧪

Looking for a co-op role for next term? We're #hiring! Kick-start your career with Aspect and contribute to our mission to transform medicine with bioprinted tissue therapeutics.   

See open roles here 👉 https://buff.ly/2z1cfay 
#AspectLife 

Metric
Company Name	Aspect Biosystems
Symbol
MSH ID	COM:ASPECTBIOSYSTEMS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	CA
Stage
Employee Count	100
Website	aspectbiosystems.com
LinkedIn	aspect-biosystems
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ASPECTBIOSYSTEMS

Aspect Biosystems

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue